보고서 요약(국문)

개요
글로벌 생체 임피던스 분석기 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) XX%로 성장하여 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
생체 임피던스 분석기(BIA)는 간단하고 저렴하며 비침습적인 체성분 측정 방법입니다. BIA는 인체의 전기 전도 특성을 기반으로 합니다. 생체 전기 전도도 측정값은 총 체수분량과 체지방 및 골격근량과 같이 수분 농도가 높은 신체 부위에 비례합니다. BIA는 인체가 지방과 제지방량(FFM, 체중)의 두 부분으로 구성되어 있다고 가정합니다. BIA는 체지방률 측정 기술로 가장 잘 알려져 있지만, 최근에는 골격근량 측정에도 사용되고 있습니다.

시장 동향: 성장 동력 및 제약 요인
생활습관병 유병률 증가
비만, 고혈압, 당뇨병 등 다양한 생활습관병의 유병률 증가는 주로 좌식 근무 환경, 정크푸드 과다 섭취, 이동 수단 자동화 증가와 같은 건강하지 못한 생활 습관 때문인 것으로 추정됩니다.

예를 들어, 2023년 세계 비만 아틀라스에 따르면 2020년 26억 명 이상에서 2035년에는 40억 명 이상으로 비만 인구가 증가할 것으로 예상됩니다. 즉, 2020년 세계 인구의 38%에서 2035년에는 50% 이상으로 증가할 것으로 전망됩니다. 비만(BMI 230kg/m²) 유병률만 보더라도 같은 기간 동안 인구의 14%에서 24%로 증가하여 2035년에는 약 20억 명의 성인, 어린이 및 청소년에게 영향을 미칠 것으로 예상됩니다.
또한, 전 세계 생체 임피던스 분석기 시장은 신체 활동 및 건강 관리를 장려하는 정부 및 기관의 이니셔티브 증가와 건강한 라이프스타일에 대한 관심 증대와 같은 다양한 요인에 의해 성장하고 있습니다.
시장 동향: 제약 요인
생체 임피던스 분석기의 높은 가격은 예측 기간 동안 시장 성장을 저해하는 요인 중 하나입니다. 소규모 의료 시설, 진료소 및 자원이 부족한 지역은 분석기의 높은 가격으로 인해 제약을 받을 수 있습니다. 생체 임피던스 분석기의 가격은 기능, 성능 및 주파수에 따라 다양합니다.
특히 규모가 작거나 자원이 부족한 의료 시설, 피트니스 센터 및 연구 기관의 경우 이러한 장비를 구매하고 유지하는 비용이 상당한 장벽이 될 수 있습니다. 생체 임피던스 분석기의 가격은 2,000달러에서 30,000달러까지 다양합니다.
세분화 분석
글로벌 생체 임피던스 분석기 시장은 제품 유형, 모달리티, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
제품 유형 부문에서 다중 주파수 생체 임피던스 분석기는 생체 임피던스 분석기 시장 점유율의 약 43.5%를 차지했습니다.
제품 유형 부문에서 다중 주파수 생체 임피던스 분석기 부문은 약 43.5%를 차지했으며 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 다중 주파수 생체 전기 임피던스 분석(MFBIA)은 일반적으로 사용되는 단일 주파수 생체 전기 임피던스 분석과 달리 여러 주파수에서 생체 임피던스 데이터를 얻어 저주파수(예: 1kHz 또는 5kHz)에서 세포외수(ECW)를, 고주파수(예: 100kHz, 200kHz 또는 500kHz)에서 총체수분(TBW)을 정량화할 수 있다는 점에서 차이가 있습니다.
예를 들어, 위딩스는 2023년 6월에 바디 스마트 체중계를 출시했습니다. 다중 주파수 생체 전기 임피던스 분석(BIA), 정밀 체중 센서, 그리고 건강 분석 및 통찰력을 제공하는 고급 알고리즘을 결합한 위딩스 정밀 기술을 특징으로 하는 이 보급형 체중계는 정확한 체중 및 체성분 분석은 물론 심박수, 내장지방, 대사 연령, 기초대사량과 같은 고급 건강 측정 기능을 제공합니다.

지리적 분석
북미는 2022년 시장 점유율의 약 38.4%를 차지했습니다.
북미는 FDA 승인, 비만율 증가, 의료비 지출 증가, 피트니스 센터 및 헬스 클럽 수 증가, 고령 인구 증가 등 다양한 요인으로 인해 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다.
예를 들어, MEDICAL IP는 2023년 6월 전신 체성분 CT 정량화 AI 소프트웨어인 DeepCatch에 대해 미국 FDA 510(k) 승인을 획득했습니다. DeepCatch는 컴퓨터 단층 촬영(CT) 스캔에서 해부학적 구조를 자동으로 분할 및 분석하고 3D 시각 및 정량적 정보를 포함하는 보고서 형태로 결과를 제공하는 SaMD(의료기기 소프트웨어)입니다. DeepCatch는 FDA 승인을 받은 유일한 AI 소프트웨어로, 전신 CT를 통해 피부, 뼈, 근육, 내장 지방, 피하지방, 내부 장기, 중추 신경계 등 다양한 신체 구성 요소를 자동으로 분석합니다.
COVID-19 영향 분석
COVID-19 팬데믹은 시장 성장에 상당한 영향을 미칠 것으로 예상되었습니다. 이는 주로 팬데믹 기간 동안 비만 위험이 높아졌기 때문입니다. 예를 들어, 2021년 8월 Diabetes Obesity and Metabolism에 발표된 논문에 따르면, 비만 유병률은 COVID-19 환자에게 있어 중요하고 잠재적으로 개선 가능한 위험 요소입니다.

시장 세분화
제품 유형별
• 다중 주파수 생체 임피던스 분석기
• 단일 주파수 생체 임피던스 분석기
• 이중 주파수 생체 임피던스 분석기
측정 방식별
• 무선 생체 임피던스 분석기
• 유선 생체 임피던스 분석기
적용 분야별
• 신체 부위별 측정
• 전신 측정
최종 사용자별
• 병원
• 클리닉
• 웰니스 센터
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
주요 글로벌 시장 참여 업체로는 Tanita Corporation, Akern, Biodynamics Corporation, Bioparhom, Biotekna, Bodystat Ltd, Charder Electronic Co. 등이 있습니다. Ltd, Evolt 360, Fook Tin Group Holding Ltd, Bodivis(Tongfang Health Technology (Beijing) Co., Ltd) 등이 주요 기업입니다.
주요 개발 사항
 2022년 4월, 체성분 분석 기술 분야의 세계적인 선두 기업인 InBody는 체수분 분석기 BWA 2.0을 출시했습니다. 이 새로운 전문가급 기기는 InBody S10에서 측정된 값을 확장하여 체성분 및 체수분 변화가 건강에 미치는 영향을 보다 자세히 분석할 수 있도록 지원합니다.

 2022년 3월, Analog Devices는 웨어러블 생체 임피던스 모니터링을 위한 저전력 고성능 아날로그 프런트 엔드 MAX30009를 출시했습니다. 이 기기는 환자 평가를 위한 임상 등급의 생체 신호 측정을 제공합니다.
보고서 구매 이유

• 제품 유형, 방식, 응용 분야, 최종 사용자 및 지역별 글로벌 생체 임피던스 분석기 시장 세분화를 시각화하고 주요 기업 및 주요 업체를 파악하기 위함입니다.

• 트렌드 분석 및 공동 개발을 통해 상업적 기회를 파악합니다.

• 모든 세그먼트를 포함한 생체 임피던스 분석기 시장 수준의 다양한 데이터가 담긴 엑셀 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함한 제품 맵핑 자료를 엑셀 파일로 제공합니다.

글로벌 생체 임피던스 분석기 시장 보고서는 약 77개의 표, 79개의 그림, 187페이지 분량입니다.
주요 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Bioimpedance Analyzers Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX % during the forecast period 2023-2030.
Bioimpedance analyzers is a simple, inexpensive, and noninvasive body composition measurement method. BIA is based on the electrical conductive properties of the human body. Measures of bioelectrical conductivity are proportional to total body water and the body compartments with high water concentrations such as fat-free and skeletal muscle mass. BIA assumes that the body consists of two compartments, fat and fat-free mass (FFM) (Body weight). BIA is best known as a technique for the measurement of percent body fat although it has more recently been used for estimating skeletal muscle mass too.
Market Dynamics: Drivers and Restraints
Rise in the prevalence of lifestyle diseases
The rising prevalence of various lifestyle diseases, such as obesity, high blood pressure, and diabetes, is probably due to unhealthy lifestyles, such as sedentary work environments, eating more junk food, and increased mobility automation.
For instance, according to the World Obesity Atlas 2023, over 4 billion people may be affected by 2035, compared with over 2.6 billion in 2020. Thus, there is an increase from 38% of the world's population in 2020 to over 50% by 2035. The prevalence of obesity (BMI 230kg/m2) alone is anticipated to rise from 14% to 24% of the population over the same period, affecting nearly 2 billion adults, children, and adolescents by 2035.
Furthermore, the global bioimpedance analyzers market is also driven by various other factors like, the rising number of government and organizational initiatives for promoting physical activity and healthcare coupled with growing responsiveness regarding the healthy lifestyle drives the bioimpedance analyzers market.
Market Dynamics: Restraint
The high cost of bioimpedance analyzers is one of the factors that hamper the market growth during the forecast period. The smaller healthcare facilities, clinics, and resource-constrained regions will be limited by the high cost of analyzers. Depending on the features, capabilities, and frequency, bioimpedance analyzers can range in pricing.
For some healthcare facilities, fitness centres, and research institutions, especially smaller or resource-constrained organizations, the cost of acquiring and maintaining these devices can be a significant barrier. The price of bioimpedance analyzers can range from USD 2,000- USD 30,000.
Segment Analysis
The global bioimpedance analyzers market is segmented based on product type, modality, application, end user and region.
The multi-frequency bioimpedance analyzers from the product type segment accounted for approximately 43.5% of the bioimpedance analyzers market share
The multi-frequency bioimpedance analyzers segment from the product type segment accounted for approximately 43.5% and is expected to be dominated during the forecast period. Multi-frequency bioelectrical impedance analysis (MFBIA) differs from the more commonly utilized single-frequency bioelectrical impedance analysis in that bioimpedance data is obtained at several different frequencies, allowing for quantification of extracellular water (ECW) at low frequencies (e.g. 1 or 5 kHz), and total body water (TBW) at higher frequencies (e.g. 100, 200, or 500 kHz).
For instance, in June 2023, Withings introduced the Body Smart Scale. Featuring Withings Precision Technology that combines multifrequency bioelectrical impedance analysis (BIA), precision weight sensors, and advanced algorithms delivering insights and health analysis, the entry-level scale provides precise weight and body composition analysis as well as advanced health measurements including heart rate, visceral fat, metabolic age and basal metabolic rate.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the various factors, such as FDA clearance, increases in obesity rates, increasing healthcare spending, a growing number of fitness centers and health clubs, and an increasing geriatric population which helps the region to have highest market share during the forecast period.
For instance, in June 2023, MEDICAL IP received US FDA 510(k) Clearance for DeepCatch, AI Software for Whole-Body Composition CT Quantification. DeepCatch is a SaMD (Software as a Medical Device) that automatically segments and analyzes anatomical structures in computed tomography (CT) scans and provides the results as a report with 3D visual and quantitative information. DeepCatch is the only FDA-cleared AI software that automatically analyzes various body components such as skin, bone, muscle, visceral fat, subcutaneous fat, internal organs, and central nervous system through whole-body CT.
COVID-19 Impact Analysis
The COVID-19 pandemic was expected to have a significant impact on market growth. This was mainly due to the high risk of obesity during the pandemic period. For instance, according to the article published in Diabetes Obesity and Metabolism in August 2021, obesity prevalence is a significant and potentially modifiable risk factor among COVID-19 patients.
Market Segmentation
By Product Type
• Multi-Frequency Bioimpedance Analyzers
• Single Frequency Bioimpedance Analyzers
• Dual Frequency Bioimpedance Analyzers
By Modality
• Wireless Bioimpedance Analyzers
• Wired Bioimpedance Analyzers
By Application
• Segmental Body Measurement
• Whole Body Measurement
By End User
• Hospitals
• Clinics
• Wellness Centers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Tanita Corporation, Akern, Biodynamics Corporation, Bioparhom, Biotekna, Bodystat Ltd, Charder Electronic Co. Ltd, Evolt 360, Fook Tin Group Holding Ltd, Bodivis( Tongfang Health Technology (Beijing) Co., Ltd) among others.
Key Developments
 In April 2022, InBody, a worldwide leader in body composition technology, stated the release of its BWA 2.0 body water analyzer. This new professional-grade device expands upon the outputs measured by the InBody S10 to provide users with more detailed insights that demonstrate how variations in body composition and body water can affect well-being.
 In March 2022, Analog Devices launched a low-power, high-performance analogue front end built for wearable bioimpedance monitoring, MAX30009. This device promised clinical-grade vital sign measurement for patient assessment.
Why Purchase the Report?
• To visualize the global bioimpedance analyzers' market segmentation based on product type, modality, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of bioimpedance analyzers market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global bioimpedance analyzers market report would provide approximately 77 tables, 79 figures and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Modality
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the prevalence of lifestyle diseases
4.1.1.2. Rise in the technological advancements
4.1.2. Restraints
4.1.2.1. High cost of bioimpedance analyzers
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Multi-Frequency Bioimpedance Analyzers*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Single Frequency Bioimpedance Analyzers
7.4. Dual Frequency Bioimpedance Analyzers
8. By Modality
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
8.1.2. Market Attractiveness Index, By Modality
8.2. Wireless Bioimpedance Analyzers*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Wired Bioimpedance Analyzers
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Segmental Body Measurement*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Whole Body Measurement
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Clinics
10.4. Wellness Centers
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.6.1. China
11.5.6.2. India
11.5.6.3. Japan
11.5.6.4. Australia
11.5.6.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Tanita Corporation *
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Akern
13.3. Biodynamics Corporation
13.4. Bioparhom
13.5. Biotekna
13.6. Bodystat Ltd
13.7. Charter Electronic Co. Ltd
13.8. Evolt 360
13.9. Fook Tin Group Holding Ltd
13.10. Bodivis( Tongfang Health Technology (Beijing) Co.,Ltd)
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Tanita Corporation, 4.	Key Developments, Akern, Biodynamics Corporation, Bioparhom, Biotekna, Bodystat Ltd, Charter Electronic Co. Ltd, Evolt 360, Fook Tin Group Holding Ltd, Bodivis( Tongfang Health Technology (Beijing) Co.,Ltd)

표 목록 (Tables)

List of Tables

Table 1 Global Bioimpedance Analyzers Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Bioimpedance Analyzers Market Value, By Modality, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Bioimpedance Analyzers Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Bioimpedance Analyzers Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Bioimpedance Analyzers Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Bioimpedance Analyzers Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 7 Global Bioimpedance Analyzers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 8 Global Bioimpedance Analyzers Market Value, By Modality, 2023, 2027 & 2031 (US$ Million)

Table 9 Global Bioimpedance Analyzers Market Value, By Modality, 2022-2031 (US$ Million)

Table 10 Global Bioimpedance Analyzers Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 11 Global Bioimpedance Analyzers Market Value, By Application, 2022-2031 (US$ Million)

Table 12 Global Bioimpedance Analyzers Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 13 Global Bioimpedance Analyzers Market Value, By End User, 2022-2031 (US$ Million)

Table 14 Global Bioimpedance Analyzers Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 15 Global Bioimpedance Analyzers Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America Bioimpedance Analyzers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 17 North America Bioimpedance Analyzers Market Value, By Modality, 2022-2031 (US$ Million)

Table 18 North America Bioimpedance Analyzers Market Value, By Application, 2022-2031 (US$ Million)

Table 19 North America Bioimpedance Analyzers Market Value, By End User, 2022-2031 (US$ Million)

Table 20 North America Bioimpedance Analyzers Market Value, By Country, 2022-2031 (US$ Million)

Table 21 South America Bioimpedance Analyzers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 22 South America Bioimpedance Analyzers Market Value, By Modality, 2022-2031 (US$ Million)

Table 23 South America Bioimpedance Analyzers Market Value, By Application, 2022-2031 (US$ Million)

Table 24 South America Bioimpedance Analyzers Market Value, By End User, 2022-2031 (US$ Million)

Table 25 South America Bioimpedance Analyzers Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe Bioimpedance Analyzers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 27 Europe Bioimpedance Analyzers Market Value, By Modality, 2022-2031 (US$ Million)

Table 28 Europe Bioimpedance Analyzers Market Value, By Application, 2022-2031 (US$ Million)

Table 29 Europe Bioimpedance Analyzers Market Value, By End User, 2022-2031 (US$ Million)

Table 30 Europe Bioimpedance Analyzers Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Asia-Pacific Bioimpedance Analyzers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 32 Asia-Pacific Bioimpedance Analyzers Market Value, By Modality, 2022-2031 (US$ Million)

Table 33 Asia-Pacific Bioimpedance Analyzers Market Value, By Application, 2022-2031 (US$ Million)

Table 34 Asia-Pacific Bioimpedance Analyzers Market Value, By End User, 2022-2031 (US$ Million)

Table 35 Asia-Pacific Bioimpedance Analyzers Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East & Africa Bioimpedance Analyzers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 37 Middle East & Africa Bioimpedance Analyzers Market Value, By Modality, 2022-2031 (US$ Million)

Table 38 Middle East & Africa Bioimpedance Analyzers Market Value, By Application, 2022-2031 (US$ Million)

Table 39 Middle East & Africa Bioimpedance Analyzers Market Value, By End User, 2022-2031 (US$ Million)

Table 40 Tanita Corporation: Overview

Table 41 Tanita Corporation: Product Portfolio

Table 42 Tanita Corporation: Key Developments

Table 43 Akern: Overview

Table 44 Akern: Product Portfolio

Table 45 Akern: Key Developments

Table 46 Biodynamics Corporation: Overview

Table 47 Biodynamics Corporation: Product Portfolio

Table 48 Biodynamics Corporation: Key Developments

Table 49 Bioparhom: Overview

Table 50 Bioparhom: Product Portfolio

Table 51 Bioparhom: Key Developments

Table 52 Biotekna: Overview

Table 53 Biotekna: Product Portfolio

Table 54 Biotekna: Key Developments

Table 55 Bodystat Ltd: Overview

Table 56 Bodystat Ltd: Product Portfolio

Table 57 Bodystat Ltd: Key Developments

Table 58 Charter Electronic Co. Ltd: Overview

Table 59 Charter Electronic Co. Ltd: Product Portfolio

Table 60 Charter Electronic Co. Ltd: Key Developments

Table 61 Evolt 360: Overview

Table 62 Evolt 360: Product Portfolio

Table 63 Evolt 360: Key Developments

Table 64 Fook Tin Group Holding Ltd: Overview

Table 65 Fook Tin Group Holding Ltd: Product Portfolio

Table 66 Fook Tin Group Holding Ltd: Key Developments

Table 67 Bodivis( Tongfang Health Technology (Beijing) Co.,Ltd): Overview

Table 68 Bodivis( Tongfang Health Technology (Beijing) Co.,Ltd): Product Portfolio

Table 69 Bodivis( Tongfang Health Technology (Beijing) Co.,Ltd): Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 2 Global Bioimpedance Analyzers Market Share, By Product Type, 2022 & 2031 (%)

Figure 3 Global Bioimpedance Analyzers Market Share, By Modality, 2022 & 2031 (%)

Figure 4 Global Bioimpedance Analyzers Market Share, By Application, 2022 & 2031 (%)

Figure 5 Global Bioimpedance Analyzers Market Share, By End User, 2022 & 2031 (%)

Figure 6 Global Bioimpedance Analyzers Market Share, By Region, 2022 & 2031 (%)

Figure 7 Global Bioimpedance Analyzers Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 8 Multi-Frequency Bioimpedance Analyzers Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 9 Single Frequency Bioimpedance Analyzers Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 10 Dual Frequency Bioimpedance Analyzers Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 11 Global Bioimpedance Analyzers Market Y-o-Y Growth, By Modality, 2022-2031 (%)

Figure 12 Wireless Bioimpedance Analyzers Modality in Global Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 13 Wired Bioimpedance Analyzers Modality in Global Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 14 Global Bioimpedance Analyzers Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 15 Segmental Body Measurement Application in Global Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 16 Whole Body Measurement Application in Global Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 17 Global Bioimpedance Analyzers Market Y-o-Y Growth, By End User, 2022-2031 (%)

Figure 18 Hospitals End User in Global Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 19 Clinics End User in Global Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 20 Wellness Centers End User in Global Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 21 Others End User in Global Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 22 Global Bioimpedance Analyzers Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 23 North America Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 24 Asia-Pacific Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 25 Europe Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 26 South America Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 27 Middle East and Africa Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 28 North America Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 29 North America Bioimpedance Analyzers Market Share, By Product Type, 2022 & 2031 (%)

Figure 30 North America Bioimpedance Analyzers Market Share, By Modality, 2022 & 2031 (%)

Figure 31 North America Bioimpedance Analyzers Market Share, By Application, 2022 & 2031 (%)

Figure 32 North America Bioimpedance Analyzers Market Share, By End User, 2022 & 2031 (%)

Figure 33 North America Bioimpedance Analyzers Market Share, By Country, 2022 & 2031 (%)

Figure 34 South America Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 35 South America Bioimpedance Analyzers Market Share, By Product Type, 2022 & 2031 (%)

Figure 36 South America Bioimpedance Analyzers Market Share, By Modality, 2022 & 2031 (%)

Figure 37 South America Bioimpedance Analyzers Market Share, By Application, 2022 & 2031 (%)

Figure 38 South America Bioimpedance Analyzers Market Share, By End User, 2022 & 2031 (%)

Figure 39 South America Bioimpedance Analyzers Market Share, By Country, 2022 & 2031 (%)

Figure 40 Europe Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 41 Europe Bioimpedance Analyzers Market Share, By Product Type, 2022 & 2031 (%)

Figure 42 Europe Bioimpedance Analyzers Market Share, By Modality, 2022 & 2031 (%)

Figure 43 Europe Bioimpedance Analyzers Market Share, By Application, 2022 & 2031 (%)

Figure 44 Europe Bioimpedance Analyzers Market Share, By End User, 2022 & 2031 (%)

Figure 45 Europe Bioimpedance Analyzers Market Share, By Country, 2022 & 2031 (%)

Figure 46 Asia-Pacific Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 47 Asia-Pacific Bioimpedance Analyzers Market Share, By Product Type, 2022 & 2031 (%)

Figure 48 Asia-Pacific Bioimpedance Analyzers Market Share, By Modality, 2022 & 2031 (%)

Figure 49 Asia-Pacific Bioimpedance Analyzers Market Share, By Application, 2022 & 2031 (%)

Figure 50 Asia-Pacific Bioimpedance Analyzers Market Share, By End User, 2022 & 2031 (%)

Figure 51 Asia-Pacific Bioimpedance Analyzers Market Share, By Country, 2022 & 2031 (%)

Figure 52 Middle East & Africa Bioimpedance Analyzers Market Value, 2022-2031 (US$ Million)

Figure 53 Middle East & Africa Bioimpedance Analyzers Market Share, By Product Type, 2022 & 2031 (%)

Figure 54 Middle East & Africa Bioimpedance Analyzers Market Share, By Modality, 2022 & 2031 (%)

Figure 55 Middle East & Africa Bioimpedance Analyzers Market Share, By Application, 2022 & 2031 (%)

Figure 56 Middle East & Africa Bioimpedance Analyzers Market Share, By End User, 2022 & 2031 (%)

Figure 57 Tanita Corporation: Financials

Figure 58 Akern: Financials

Figure 59 Biodynamics Corporation: Financials

Figure 60 Bioparhom: Financials

Figure 61 Biotekna: Financials

Figure 62 Bodystat Ltd: Financials

Figure 63 Charter Electronic Co. Ltd: Financials

Figure 64 Evolt 360: Financials

Figure 65 Fook Tin Group Holding Ltd: Financials

Figure 66 Bodivis( Tongfang Health Technology (Beijing) Co.,Ltd): Financials

글로벌 생체 임피던스 분석기 시장 – 2023-2030

Global Bioimpedance Analyzers Market - 2023-2030